Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.44 |
| ▸ | FNTB | P49356 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585195 | 0.93 | ALOX15 (0.55) | ALOX15ALDH1A1USP2FNTAFNTB | |
| SCHEMBL30792423 | 0.93 | ALOX15 (0.55) | ALOX15ALDH1A1USP2FNTAFNTB | |
| Acetic Acid SCHEMBL30029703 | 0.92 | ALOX15 (0.53) | ALOX15ALDH1A1USP2FNTAFNTB | |
| Citronellol SCHEMBL27905065 | 0.91 | ALOX15 (0.64) | ALOX15ALDH1A1USP2FNTAFNTB | |
| Citronellol SCHEMBL27904970 | 0.88 | ALOX15 (0.60) | ALOX15ALDH1A1USP2PTPN1TSHR | |
| Citronellic Acid SCHEMBL30505625 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2FNTAFNTB | |
| Citronellol SCHEMBL28237269 | 0.87 | ALOX15 (0.68) | ALOX15ALDH1A1USP2FNTAFNTB | |
| Citronellol SCHEMBL15902426 | 0.86 | ALOX15 (0.84) | ALOX15ALDH1A1USP2FNTAFNTB | |
| SCHEMBL10898399 | 0.86 | FNTA (0.62) | ALOX15ALDH1A1FNTAFNTB | |
| Citronellol SCHEMBL27652866 | 0.86 | ALOX15 (0.66) | ALOX15ALDH1A1USP2FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119546194-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| EP-4251313-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022167123-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022112204-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | ALOX15 158/4885ALDH1A1 116/4885USP2 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.